Lite Strategy (LITS) Tax Provisions (2011 - 2019)
Lite Strategy (LITS) posted Tax Provisions of -$3.5 million for Q2 2019, down 353400.0% on a QoQ basis from $1000.0 in Q3 2018.
Analysis
Lite Strategy (LITS) Tax Provisions (2011 - 2019) Analysis & Trends
Lite Strategy has reported Tax Provisions for 9 years, with the latest figure at -$3.5 million in Q2 2019.
- On a quarterly basis, Tax Provisions changed N/A year-over-year to -$3.5 million in Q2 2019; TTM through Jun 2019 was -$3.5 million, a 353300.0% decrease from a year earlier, with the FY2022 full-year figure at -$11.4 million, down 31.83% from the prior year.
- Tax Provisions was -$3.5 million for Q2 2019 at Lite Strategy, down from $1000.0 in the prior quarter.
- The five-year high for Tax Provisions was $1000.0 in Q3 2015, with the low at -$11.1 million in Q2 2015.
- Average Tax Provisions over 5 years is -$3.1 million, with a median of $1000.0 recorded in 2015.
- The sharpest annual moves came in 2015 and 2016: Tax Provisions fell 20.44% in 2015, then surged 36.19% in 2016.
- Over 5 years, Tax Provisions stood at $1000.0 in 2015, then changed by 0.0% to $1000.0 in 2016, then changed by 0.0% to $1000.0 in 2017, then changed by 0.0% to $1000.0 in 2018, then slumped by 353400.0% to -$3.5 million in 2019.
- The last three Tax Provisions figures came in at -$3.5 million (Q2 2019), $1000.0 (Q3 2018), and $1000.0 (Q3 2017), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 393.00 Mn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 242.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 292.00 Mn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 230.90 Mn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | -59.00 Mn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 15.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 13.31 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 34.90 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -3.96 Mn |
| 10 | Lite Strategy | 38.03 Mn | 30.49 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2019 | -3.53 Mn |
| Sep 30, 2018 | 1,000.00 |
| Sep 30, 2017 | 1,000.00 |
| Sep 30, 2016 | 1,000.00 |
| Jun 30, 2016 | -7.09 Mn |
| Sep 30, 2015 | 1,000.00 |
| Jun 30, 2015 | -11.12 Mn |
| Dec 31, 2014 | 1,000.00 |
| Jun 30, 2014 | -9.23 Mn |
| Sep 30, 2013 | 1,000.00 |
| Jun 30, 2013 | -3.80 Mn |
| Sep 30, 2012 | 1,000.00 |
| Jun 30, 2012 | -2.56 Mn |
| Sep 30, 2011 | 1,000.00 |